← All indications
Pelvic Neoplasms
Tumors or cancer of the pelvic region.
Drugs by status
Phase 3 trials (4)
Phase 2 trials (3)
Phase 1 trials (8)
Other trials (2)
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (15)
- Seattle Genetics
- Astellas
- AstraZeneca
- Genentech
- Bayer
- Temple University
- Mayo Clinic
- Capital Medical University
- Cancer Immunotherapy Trials Network
- Royal Marsden Hospital NHS Trust
- Karolinska Institute
- City of Hope National Medical Center
- University of Texas at Houston
- University of Alabama, Birmingham
- Government of Malaysia
Organization Involved with Phase 1 Indications (16)
- Pierre Fabre
- MedImmune
- Pfizer
- Novartis
- Light Sciences Oncology
- OncoGenex Technologies
- National Institutes of Health (NIH)
- Cornell University
- Osaka University
- Thomas Jefferson University
- University of Oslo
- University of South Florida
- Columbia University
- University of Minnesota
- Nordic Urothelial Cancer Oncology Group
- St. Jude Children's Hospital
Organization Involved with Other Experimental Indications (1)